Results 121 to 130 of about 252,658 (290)
EVALUATION OF SOFTWARE METRICS FOR SOFTWARE PROJECTS
Kunal Chopra, Monika Sachdeva
openalex +2 more sources
Analysis of Developers’ Network and Change Burst Metrics as Predictors of Software Faults [PDF]
Malanga Ndenga +82 more
openalex +1 more source
Undersøkte hva som står i literatur om måleenheter i software startup bedrifter. Samlet måleenheter fra literatur og internett, undersøkte via en spørreundersøkelse om bedrifter bruker disse, og hvordan de brukes.
openaire +1 more source
ATF4‐mediated stress response as a therapeutic vulnerability in chordoma
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone +11 more
wiley +1 more source
Best practices to evaluate the impact of biomedical research software-metric collection beyond citations. [PDF]
Afiaz A +26 more
europepmc +1 more source
Software Quality Factors and Software Quality Metrics to Enhance Software Quality Assurance
Ming‐Chang Lee
openalex +2 more sources
Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken +7 more
wiley +1 more source
myAURA: a personalized health library for epilepsy management via knowledge graph sparsification and visualization. [PDF]
Correia RB +14 more
europepmc +1 more source
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source

